Page results
-
An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.
-
UCLH Find & Treat team explain why screening is vital on World Hepatitis Day
-
The hospital marked the start of the year a visit by HM The Queen in February 2020. A few weeks after this celebration, the pandemic took hold and the hospital stepped up to help.
-
Specialist teams at UCLH and UCL are at the forefront of research which could bring hope to people who have been robbed of their sense of smell and taste after suffering the long-term legacy of COVID-19.
-
The Sickle Cell Society (SCS) and the UK Thalassaemia Society (UKTS) have worked in partnership with the NHS sickle cell and thalassaemia (SCT) screening programme to engage with communities less likely to access health information through usual NHS channels. The societies provide feedback from people that share the same population background or have experience of the condition and to feed into the programme updates and improvements.
-
Education and training videos for Red Cell Network patients
-
Patient information for Red Cell Network patients
-
A study of patients at UCLH and North Middlesex University Hospital published in The Lancet Infectious Diseases suggests that the B.1.17. variant of Covid-19 is not associated with more severe illness and death, but appears to lead to higher virus load.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
File results
-
FOI/2024/0720 - Motion picture licensing corporation
-
FOI/2024/0721 - New biologic and targeted medications/ treatment within dermatology
-
FOI/2024/0734 - Treatment and management of patients with Lupus 2023
-
FOI/2024/0736 - Outpatient/ elective activity performed on 14th-16th June 2023
-
FOI/2024/0737 - Outpatient/ elective activity performed on 13th-17th July 2023
-
FOI/2024/0741 - HR, finance and payroll contracts/ software updates/ staff contact details
-
FOI/2024/0742 - CIO and Chief Data Officer staff contact details/ data tools and technologies/ spend
-
FOI/2024/0743 - Maternal deaths/ stillbirths/ intrapartum deaths/ births with confirmed or suspected hypoxic ischemic encephalopathy for 2021-2023
-
FOI/2024/0744 - Software solution for collection and management of patient observations-data in ICU/ anaesthesia
-
FOI/2024/0745 - Infrastructure risks, repairs, failure. Wait times, bed/admission capacity, maternity units and mortuary space 2019-2024